Search
Filter Results
Displaying 921–930 of 1028 results
-
Jul 1, 2016
Dr. Weleber became the 10th recipient of the Foundation’s highest honor, named after FFB co-founder Lulie Gund, during the opening lunch of the VISIONS 2016 conference.
-
Jul 1, 2016
At VISIONS 2016, FFB’s national conference, the Foundation honored him with its Ed Gollob Board of Directors Award for breakthrough research conducted within the past year.
-
Jun 27, 2016
Two Philanthropic Brothers — Selling Luxury Casual Wear for the Good of Retinal Research
The story of Two Blind Brothers, a luxury clothing line that donates its proceeds to retinal research.
-
Jun 27, 2016
Two Philanthropic Brothers — Selling Luxury Casual Wear for the Good of Retinal Research
The story of Two Blind Brothers, a luxury clothing line that donates its proceeds to retinal research.
-
Jun 24, 2016
A Steady Hand in Saving Vision
Subretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
Jun 6, 2016
Fighting Blindness Gets Sheepish
Researchers in Israel are developing a gene therapy for achromatopsia that may help both sheep and humans alike.
-
May 5, 2016
ARVO 2016: High-School Sophomore Finds Gene Mutation in Family with Choroideremia
Aditya A. Guru, 16, used whole exome sequencing (WES), an innovative genetic-screening technology, to find the mutation.
-
May 4, 2016
ARVO 2016: Emerging Drug Targets Toxic Build-Up in Stargardt Disease
In August 2015, the biotech company Alkeus launched a multi-center TEASE Phase II clinical trial for the drug ALK-001.
-
May 3, 2016
ARVO 2016: What Does It Take to Develop a Stem-Cell Therapy for the Retina?
There are innumerable considerations for researchers developing therapies.